Prevention and reversal of renal allograft rejection by monoclonal antibody to CD45RB in the mouse model
Zhang, Z.; Zhong, R.; Grant, D.; Garcia, B.; White, M.; Stiller, C.; Lazarovits, A.
Transplantation Proceedings 27(1): 389
1995
ISSN/ISBN: 0041-1345 PMID: 7879031 Document Number: 452543
Document emailed within 1 workday
Related Documents
Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection Chinese Medical Journal 106(11): 821-824Lácha, J.; Lehmann, M.; Chadimová, M.; Brock, J.; Havlícková, J. 1994: Effect of anti-CD4 monoclonal antibody and cyclosporine a or a combination of both on chronic rejection in the rat aortic allograft model Transplantation Proceedings 26(6): 3242-3243
d'Apice, A.J.; Thurlow, P.J.; Ihle, B.U.; Lovering, E.K.; McKenzie, I.F. 1987: Treatment of acute renal allograft rejection with a monoclonal antibody to a T cell antigen (HuLy-m2) Australian and New Zealand Journal of Medicine 17(2): 210-215
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Hayes, J.M.; Spencer, W.; Valenzuela, R.; Caulfield, M.; Novick, A.C. 1989: Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model Transplantation Proceedings 21(1 Part 1): 1006-1009
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Roy-Chaudhury, P.; Nickerson, P.W.; Manfro, R.C.; Zheng, X.X.; Steiger, J.; Li, Y.S.; Strom, T.B. 1997: CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model Transplantation 64(1): 172-175
Stuart, F.P.; Fitch, F.W.; Rowley, D.A. 1970: Specific suppression of renal allograft rejection by treatment with antigen and antibody Transplantation Proceedings 2(4): 483-488
McKearn, T.J.; Finnegan, A.; Neu, M.R.; Fitch, F.W.; Stuart, F.P. 1974: Suppression of rat renal allograft rejection by antibody against lymphocyte antigen receptors Surgical Forum 25: 263-265
Haiyan, X.; Xiaozhou, H.; Wei, Z.; Hui, G.; Qianqian, S.; Yibei, Z.; Xueguang, Z. 2012: CD256 Can be Found in Antibody-Mediated Renal Allograft Rejection Tissues Clinical Laboratory 58(5-6): 411-418
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
Thomas, J.; Thomas, F.; Lee, H.M. 1977: Studies of lymphocyte-dependent antibody in human chronic renal allograft rejection Transplantation Proceedings 9(1): 65-68
Vossen, A.C.; Tibbe, G.J.; van Oudenaren, A.; Vredendaal, A.E.; Benner, R.; Savelkoul, H.F. 1994: A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects Transplantation Proceedings 26(6): 3157-3158
Woodle, E.S.; Xu, D.; Zivin, R.A.; Auger, J.; Charette, J.; O'Laughlin, R.; Peace, D.; Jollife, L.K.; Haverty, T.; Bluestone, J.A.; Thistlethwaite, J.R. 1999: Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection Transplantation 68(5): 608-616
Boillot, A.; Massol, J.; Maupoil, V.; Grelier, R.; Bernard, B.; Capellier, G.; Berthelot, A.; Barale, F. 1997: Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody Critical Care Medicine 25(3): 504-511
Behrend, M.; Lück, R.; Köthe, P.; Pichlmayr, R. 1996: A single center experience with mycophenolate mofetil in the prevention of renal allograft rejection Transplantation Proceedings 28(6): 3110-3111
Braun, C.; Conzelmann, T.; Vetter, S.; Schaub, M.; Back, W.E.; Yard, B.; Kirchengast, M.; Tullius, S.G.; Schnülle, P.; van der Woude, F.J.; Rohmeiss, P. 1999: Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist Transplantation 68(6): 739-746
Esquivel, C.O.; Fung, J.J.; Markus, B.; Iwatsuki, S.; Gordon, R.D.; Makowka, L.; Marsh, J.W.; Tzakis, A.G.; Todo, S.; Starzl, T.E. 1987: OKT3 in the reversal of acute hepatic allograft rejection Transplantation Proceedings 19(1 Part 3): 2443-2446
Yoshimura, N.; Lee, C.J.; Shiho, O.; Kita, M.; Imanishi, J.; Oka, T. 1995: Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells Transplantation Proceedings 27(1): 390-391